Tatiana Prowell, Associate Professor of Oncology at Johns Hopkins School of Medicine and Breast Cancer Scientific Liaison at the U.S. Food and Drug Administration, shared a post on X:
“NEW FDA Draft Guidance on Overall Survival in Oncology Clinical Trials, covering trial design, biostats considerations, posthoc and subgroup analyses, and more. Public comment period open now thru 10/20/2025.”
More posts featuring Tatiana Prowell on OncoDaily.